How Do You Qualify a Doctor to Do Focal Therapy?

It is the repetition of affirmations that leads to belief. And once that belief becomes a deep conviction, things begin to happen.” Muhammad Ali 

This is a blog about focal therapy for prostate cancer. More importantly, it is about the essential need for doctors to have a foundation of belief that supports focal therapy.

One of the ongoing themes in my blogs is the importance of matching a patient’s prostate cancer with the treatment for which he is best qualified. The lower the risk, the more treatment options will be open, possibly including focal therapy. However, “bulky” intermediate-to-high risk prostate cancer excludes focal treatment because it requires a more aggressive approach.

In looking for recent journal articles on focal therapy for prostate cancer, one title immediately stood out: Focal Ablation of Prostate Cancer.[i] It is a summary review on the current status of focal ablation. Topics include content I would expect: historical context; advances in screening, imaging, and diagnosis; patient selection; energies to deliver ablation, etc. But one topic seemed exceptional: “What you must believe.”

If you ask a patient what qualifies his doctor to offer, say, robotic prostatectomy, his answers might include things like

  • Clinical and technical training
  • Experience and practice
  • Financial resources
  • Access to appropriate equipment and devices, etc.

How often does it occur to the patient that the doctor must have the conviction and mindset that supports his or her confidence in the treatment? Don’t we all take that for granted?

Focal therapy: what must a doctor believe?

For any given therapy or treatment, the doctor who is delivering it must believe wholeheartedly in the treatment itself. I have had my own professional journey from curiosity and theory to deeply held belief that focal treatment – in particular, focal laser ablation (FLA) – is safe and effective for qualified patients. During all those years, I observed a growing shift in the field of urology away from cherished, time-honored beliefs. As research evidence accumulated, urologists were faced with new possibilities that challenged long-held assumptions. Three examples include:

  1. Prostate cancer is a multifocal disease.
  2. All prostate cancer, including Gleason 3+3, is life-threatening and must be treated aggressively.
  3. An elevated PSA requires immediate biopsy.

These and many other concepts often limited options offered by urologists to their patients.

Therefore, it came as a welcome surprise to discover that the authors of the article (all affiliated with
the Department of Urology, NYU Langone Medical Center) identified five beliefs that qualify doctors to perform focal therapy, in addition to their clinical and technical skills.  According to the authors, in order to treat prostate cancer focally, doctors must believe that

  1. Untreated insignificant PCa is of no immediate risk
  2. MRI identifies the index lesion
  3. MRI rarely fails to detect significant disease
  4. Ablation can be reliably delivered to pre-defined targets
  5. Preserving quality of life is a high priority for men with localized PCa.

Confidence in our beliefs

 At the Sperling prostate center, we are proud to be in the vanguard of imaging and focal laser ablation.  For years, our clinical work and patient services have demonstrated results that support those five beliefs.  In conjunction with leading experts who are our global colleagues, we have made it our mission to ensure a sturdy belief platform of prostate cancer detection and diagnosis using multi-parametric MRI and MRI- guided FLA. It has indeed been our experience that when belief became a deep conviction, things truly happened.

NOTE: This content is solely for purposes of information and does not substitute for diagnostic or medical advice. Talk to your doctor if you are experiencing pelvic pain, or have any other health concerns or questions of a personal medical nature.


[i] Lepor H, Gold S, Wysock MD. Focal Ablation of Prostate CancerRev Urol. 2018; 20(4):145–157. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375006/

You may also be interested in...

This site uses cookies to analyze traffic and user behavior, protect your privacy, and provide you with the best user experience. Learn more.
close-image

How can we help?

Contact us to discuss your prostate health and plan your path to wellness.

close-link